{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T04:14:09Z","timestamp":1746591249866,"version":"3.40.5"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,6]]},"DOI":"10.7759\/cureus.83550","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T07:46:32Z","timestamp":1746517592000},"source":"Crossref","is-referenced-by-count":0,"title":["Paraneoplastic Trichomegaly as a Harbinger of Metastatic Renal Cell Carcinoma: A Case Report"],"prefix":"10.7759","author":[{"given":"Allison","family":"Reichl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rena","family":"Callahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel RL","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023, 73:17-48. 10.3322\/caac.21763","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2018.08.036","article-title":"Epidemiology of renal cell carcinoma","volume":"75","author":"Capitanio U","year":"2019","unstructured":"Capitanio U, Bensalah K, Bex A, et al.. Epidemiology of renal cell carcinoma. Eur Urol. 2019, 75:74-84. 10.1016\/j.eururo.2018.08.036","journal-title":"Eur Urol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-035938","article-title":"Challenges of early renal cancer detection: symptom patterns and incidental diagnosis rate in a multicentre prospective UK cohort of patients presenting with suspected renal cancer","volume":"10","author":"Vasudev NS","year":"2020","unstructured":"Vasudev NS, Wilson M, Stewart GD, et al.. Challenges of early renal cancer detection: symptom patterns and incidental diagnosis rate in a multicentre prospective UK cohort of patients presenting with suspected renal cancer. BMJ Open. 2020, 10:e035938. 10.1136\/bmjopen-2019-035938","journal-title":"BMJ Open"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2018.08.023","article-title":"Clinical stage migration and survival for renal cell carcinoma in the United States","volume":"2","author":"Patel HD","year":"2019","unstructured":"Patel HD, Gupta M, Joice GA, Srivastava A, Alam R, Allaf ME, Pierorazio PM. Clinical stage migration and survival for renal cell carcinoma in the United States. Eur Urol Oncol. 2019, 2:343-8. 10.1016\/j.euo.2018.08.023","journal-title":"Eur Urol Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2005.11.035","article-title":"2004 WHO classification of the renal tumors of the adults","volume":"49","author":"Lopez-Beltran A","year":"2006","unstructured":"Lopez-Beltran A, Scarpelli M, Montironi R, Kirkali Z. 2004 WHO classification of the renal tumors of the adults. Eur Urol. 2006, 49:798-805. 10.1016\/j.eururo.2005.11.035","journal-title":"Eur Urol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.12848","article-title":"Renal cell carcinoma: a review","volume":"332","author":"Rose TL","year":"2024","unstructured":"Rose TL, Kim WY. Renal cell carcinoma: a review. JAMA. 2024, 332:1001-10. 10.1001\/jama.2024.12848","journal-title":"JAMA"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2023.06.015","article-title":"Incidence and clinical relevance of paraneoplastic syndromes in patients with renal cell carcinoma","volume":"41","author":"Moldovan T","year":"2023","unstructured":"Moldovan T, Boynton D, Kuperus J, et al.. Incidence and clinical relevance of paraneoplastic syndromes in patients with renal cell carcinoma. Urol Oncol. 2023, 41:392.e11-7. 10.1016\/j.urolonc.2023.06.015","journal-title":"Urol Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1053\/j.semdp.2019.01.001","article-title":"Cutaneous paraneoplastic syndromes","volume":"36","author":"Wick MR","year":"2019","unstructured":"Wick MR, Patterson JW. Cutaneous paraneoplastic syndromes. Semin Diagn Pathol. 2019, 36:211-28. 10.1053\/j.semdp.2019.01.001","journal-title":"Semin Diagn Pathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMicm2018796","article-title":"Acquired hypertrichosis lanuginosa","volume":"383","author":"Kovitwanichkanont T","year":"2020","unstructured":"Kovitwanichkanont T, Darling M. Acquired hypertrichosis lanuginosa. N Engl J Med. 2020, 383:e144. 10.1056\/NEJMicm2018796","journal-title":"N Engl J Med"},{"key":"ref10","article-title":"Trichomegaly or movie lashes","volume":"2","author":"Gray H","year":"1944","unstructured":"Gray H. Trichomegaly or movie lashes. Stanford Med Bull. 1944, 2:157-8.","journal-title":"Stanford Med Bull"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.optom.2018.05.003","article-title":"The eyelash follicle features and anomalies: a review","volume":"11","author":"Aumond S","year":"2018","unstructured":"Aumond S, Bitton E. The eyelash follicle features and anomalies: a review. J Optom. 2018, 11:211-22. 10.1016\/j.optom.2018.05.003","journal-title":"J Optom"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.9391","article-title":"Trichomegaly of the eyelashes after lung cancer treatment with the epidermal growth factor receptor inhibitor erlotinib","volume":"26","author":"Braiteh F","year":"2008","unstructured":"Braiteh F, Kurzrock R, Johnson FM. Trichomegaly of the eyelashes after lung cancer treatment with the epidermal growth factor receptor inhibitor erlotinib. J Clin Oncol. 2008, 26:3460-2. 10.1200\/JCO.2008.16.9391","journal-title":"J Clin Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-228968","article-title":"Trichomegaly of the eyelashes induced by the epidermal growth factor receptor inhibitor cetuximab in the treatment of metastatic colorectal cancer","volume":"12","author":"Matos LV","year":"2019","unstructured":"Matos LV, Pissarra A, Malheiro M, Pl\u00e1cido AN. Trichomegaly of the eyelashes induced by the epidermal growth factor receptor inhibitor cetuximab in the treatment of metastatic colorectal cancer. BMJ Case Rep. 2019, 12:e228968. 10.1136\/bcr-2018-228968","journal-title":"BMJ Case Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14217","article-title":"Biology of the eyelash hair follicle: an enigma in plain sight","volume":"174","author":"Paus R","year":"2016","unstructured":"Paus R, Burgoa I, Platt CI, Griffiths T, Poblet E, Izeta A. Biology of the eyelash hair follicle: an enigma in plain sight. Br J Dermatol. 2016, 174:741-52. 10.1111\/bjd.14217","journal-title":"Br J Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/s0190-9622(08)80972-3","article-title":"Hypertrichosis of the eyelashes in acquired immunodeficiency syndrome","volume":"123","author":"Casanova JM","year":"1987","unstructured":"Casanova JM, Puig T, Rubio M. Hypertrichosis of the eyelashes in acquired immunodeficiency syndrome. Arch Dermatol. 1987, 123:1599-601. 10.1016\/s0190-9622(08)80972-3","journal-title":"Arch Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17877","article-title":"Eyelash trichomegaly: a systematic review of acquired and congenital aetiologies of lengthened lashes","volume":"36","author":"Hutchison DM","year":"2022","unstructured":"Hutchison DM, Duffens A, Yale K, Park A, Cardenas K, Mesinkovska NA. Eyelash trichomegaly: a systematic review of acquired and congenital aetiologies of lengthened lashes. J Eur Acad Dermatol Venereol. 2022, 36:536-46. 10.1111\/jdv.17877","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1995.tb01310.x","article-title":"Acquired trichomegaly and hypertrichosis in metastatic adenocarcinoma","volume":"20","author":"V\u00e9lez A","year":"1995","unstructured":"V\u00e9lez A, Kindel\u00e1n JM, Garc\u00eda-Herola A, Garc\u00eda-L\u00e1zaro M, S\u00e1nchez-Guijo P. Acquired trichomegaly and hypertrichosis in metastatic adenocarcinoma. Clin Exp Dermatol. 1995, 20:237-9. 10.1111\/j.1365-2230.1995.tb01310.x","journal-title":"Clin Exp Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-018-2215-9","article-title":"Rare and changeable as a chameleon: paraneoplastic syndromes in renal cell carcinoma","volume":"36","author":"Hegemann M","year":"2018","unstructured":"Hegemann M, Kroeger N, Stenzl A, Bedke J. Rare and changeable as a chameleon: paraneoplastic syndromes in renal cell carcinoma. World J Urol. 2018, 36:849-54. 10.1007\/s00345-018-2215-9","journal-title":"World J Urol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-016-1793-7","article-title":"Paraneoplastic syndromes are associated with adverse prognosis among patients with renal cell carcinoma undergoing nephrectomy","volume":"34","author":"Moreira DM","year":"2016","unstructured":"Moreira DM, Gershman B, Lohse CM, Boorjian SA, Cheville JC, Leibovich BC, Thompson RH. Paraneoplastic syndromes are associated with adverse prognosis among patients with renal cell carcinoma undergoing nephrectomy. World J Urol. 2016, 34:1465-72. 10.1007\/s00345-016-1793-7","journal-title":"World J Urol"},{"key":"ref20","unstructured":"National Cancer Institute Surveillance, Epidemiology, and End Results Program. Kidney and renal pelvis SEER 5-year relative survival rates, 2014-2020. (2024). Accessed: March 14, 2025: https:\/\/seer.cancer.gov\/statistics-network\/explorer."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.4809","article-title":"Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study","volume":"27","author":"Heng DY","year":"2009","unstructured":"Heng DY, Xie W, Regan MM, et al.. Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study. J Clin Oncol. 2009, 27:5794-9. 10.1200\/JCO.2008.21.4809","journal-title":"J Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/358163-paraneoplastic-trichomegaly-as-a-harbinger-of-metastatic-renal-cell-carcinoma-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T07:46:40Z","timestamp":1746517600000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/358163-paraneoplastic-trichomegaly-as-a-harbinger-of-metastatic-renal-cell-carcinoma-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,6]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.83550","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,6]]}}}